 Eric Formeister
Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Sudden | 4 | 2022 | 11 | 2.850 |
Why?
| | Dizziness | 6 | 2026 | 101 | 2.850 |
Why?
| | Hearing Loss, Sensorineural | 4 | 2022 | 73 | 2.470 |
Why?
| | Migraine Disorders | 4 | 2022 | 112 | 1.410 |
Why?
| | Otolaryngology | 2 | 2025 | 108 | 1.260 |
Why?
| | Ergonomics | 3 | 2025 | 29 | 1.170 |
Why?
| | Temporal Bone | 3 | 2026 | 45 | 1.150 |
Why?
| | Free Tissue Flaps | 2 | 2020 | 45 | 1.110 |
Why?
| | Round Window, Ear | 4 | 2015 | 18 | 1.110 |
Why?
| | Occupational Diseases | 3 | 2025 | 165 | 1.010 |
Why?
| | Cochlear Implantation | 6 | 2023 | 82 | 0.980 |
Why?
| | Cranial Fossa, Posterior | 1 | 2026 | 20 | 0.960 |
Why?
| | Cerebrospinal Fluid Leak | 2 | 2026 | 71 | 0.930 |
Why?
| | Delayed Diagnosis | 1 | 2026 | 95 | 0.910 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2025 | 37 | 0.910 |
Why?
| | Musculoskeletal Pain | 1 | 2025 | 43 | 0.890 |
Why?
| | Semicircular Canals | 4 | 2025 | 37 | 0.880 |
Why?
| | Meniere Disease | 2 | 2022 | 36 | 0.850 |
Why?
| | Musculoskeletal Diseases | 1 | 2025 | 90 | 0.830 |
Why?
| | Hearing Loss | 3 | 2015 | 247 | 0.770 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2022 | 19 | 0.720 |
Why?
| | Tinnitus | 1 | 2022 | 68 | 0.670 |
Why?
| | Postoperative Complications | 3 | 2026 | 2920 | 0.670 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 81 | 0.660 |
Why?
| | Speech Perception | 3 | 2015 | 91 | 0.590 |
Why?
| | Vertigo | 2 | 2020 | 55 | 0.580 |
Why?
| | Laryngectomy | 1 | 2018 | 16 | 0.560 |
Why?
| | Laryngeal Neoplasms | 1 | 2018 | 35 | 0.550 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2022 | 300 | 0.520 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.500 |
Why?
| | Personnel Selection | 1 | 2017 | 93 | 0.470 |
Why?
| | Vestibular Diseases | 3 | 2021 | 57 | 0.450 |
Why?
| | Facial Nerve | 1 | 2015 | 39 | 0.440 |
Why?
| | Palate, Hard | 1 | 2014 | 5 | 0.430 |
Why?
| | Antinematodal Agents | 1 | 2014 | 7 | 0.430 |
Why?
| | Sialorrhea | 1 | 2014 | 2 | 0.430 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 562 | 0.430 |
Why?
| | Facial Dermatoses | 1 | 2014 | 17 | 0.420 |
Why?
| | Levamisole | 1 | 2014 | 21 | 0.420 |
Why?
| | Middle Aged | 15 | 2026 | 35928 | 0.420 |
Why?
| | Ear Diseases | 1 | 2014 | 18 | 0.420 |
Why?
| | Drug Contamination | 1 | 2014 | 52 | 0.420 |
Why?
| | Emergency Service, Hospital | 1 | 2026 | 2313 | 0.410 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2925 | 0.410 |
Why?
| | Machine Learning | 1 | 2020 | 587 | 0.410 |
Why?
| | Cochlear Implants | 4 | 2023 | 95 | 0.400 |
Why?
| | Humans | 34 | 2026 | 144957 | 0.400 |
Why?
| | Fellowships and Scholarships | 1 | 2017 | 357 | 0.390 |
Why?
| | Male | 22 | 2026 | 72406 | 0.390 |
Why?
| | Databases, Factual | 2 | 2018 | 1486 | 0.390 |
Why?
| | Retrospective Studies | 11 | 2026 | 17101 | 0.380 |
Why?
| | Cocaine-Related Disorders | 1 | 2014 | 132 | 0.380 |
Why?
| | Female | 22 | 2026 | 78376 | 0.380 |
Why?
| | Data Collection | 1 | 2015 | 635 | 0.370 |
Why?
| | Benign Paroxysmal Positional Vertigo | 2 | 2022 | 8 | 0.360 |
Why?
| | Cross-Sectional Studies | 6 | 2024 | 5872 | 0.350 |
Why?
| | Otologic Surgical Procedures | 3 | 2024 | 25 | 0.350 |
Why?
| | Adult | 16 | 2026 | 40506 | 0.340 |
Why?
| | Genes, Tumor Suppressor | 1 | 2010 | 83 | 0.320 |
Why?
| | Vaccination | 3 | 2022 | 1423 | 0.290 |
Why?
| | Enteroendocrine Cells | 1 | 2009 | 7 | 0.290 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 28 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 5 | 2026 | 2738 | 0.280 |
Why?
| | Aged | 10 | 2026 | 25947 | 0.280 |
Why?
| | Intestine, Small | 1 | 2009 | 166 | 0.270 |
Why?
| | Hepatitis C | 1 | 2010 | 254 | 0.260 |
Why?
| | Posture | 2 | 2025 | 196 | 0.250 |
Why?
| | Audiometry, Evoked Response | 3 | 2015 | 15 | 0.250 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2010 | 372 | 0.250 |
Why?
| | Prognosis | 4 | 2020 | 4293 | 0.230 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1258 | 0.230 |
Why?
| | Time Factors | 4 | 2026 | 7183 | 0.230 |
Why?
| | Skull Base | 2 | 2022 | 54 | 0.230 |
Why?
| | DNA Methylation | 1 | 2010 | 683 | 0.220 |
Why?
| | Cohort Studies | 4 | 2025 | 5965 | 0.220 |
Why?
| | Stem Cells | 1 | 2009 | 627 | 0.210 |
Why?
| | Liver Neoplasms | 1 | 2010 | 783 | 0.200 |
Why?
| | Audiometry | 2 | 2021 | 35 | 0.200 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 676 | 0.190 |
Why?
| | Muscle Fatigue | 1 | 2024 | 97 | 0.190 |
Why?
| | Music | 1 | 2023 | 48 | 0.190 |
Why?
| | Cranial Sinuses | 1 | 2022 | 16 | 0.190 |
Why?
| | Prevalence | 2 | 2021 | 2836 | 0.190 |
Why?
| | Risk Assessment | 2 | 2025 | 3676 | 0.190 |
Why?
| | Supervised Machine Learning | 1 | 2022 | 23 | 0.180 |
Why?
| | Chronic Disease | 2 | 2021 | 1813 | 0.180 |
Why?
| | Craniocerebral Trauma | 1 | 2024 | 176 | 0.180 |
Why?
| | Constriction, Pathologic | 1 | 2022 | 248 | 0.170 |
Why?
| | Electromyography | 1 | 2024 | 415 | 0.170 |
Why?
| | Cross-Over Studies | 1 | 2024 | 601 | 0.170 |
Why?
| | Maryland | 1 | 2021 | 66 | 0.170 |
Why?
| | Cell Proliferation | 1 | 2009 | 2499 | 0.170 |
Why?
| | Child, Preschool | 6 | 2015 | 11799 | 0.170 |
Why?
| | Cell Differentiation | 1 | 2009 | 2050 | 0.170 |
Why?
| | Disability Evaluation | 1 | 2021 | 310 | 0.150 |
Why?
| | Age Factors | 2 | 2018 | 3335 | 0.150 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6053 | 0.150 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 90 | 0.140 |
Why?
| | Pharyngectomy | 1 | 2018 | 4 | 0.140 |
Why?
| | Microvessels | 1 | 2020 | 99 | 0.140 |
Why?
| | Radiotherapy | 1 | 2018 | 206 | 0.130 |
Why?
| | Child | 7 | 2015 | 22657 | 0.130 |
Why?
| | Salvage Therapy | 1 | 2018 | 162 | 0.130 |
Why?
| | Treatment Failure | 1 | 2018 | 365 | 0.130 |
Why?
| | Survival Rate | 2 | 2019 | 2092 | 0.120 |
Why?
| | Chemoradiotherapy | 1 | 2018 | 239 | 0.120 |
Why?
| | Health Surveys | 1 | 2018 | 518 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2118 | 0.110 |
Why?
| | Graft Survival | 1 | 2018 | 526 | 0.110 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 64 | 0.110 |
Why?
| | Anatomy, Comparative | 1 | 2015 | 2 | 0.110 |
Why?
| | Attitude | 1 | 2017 | 261 | 0.110 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2015 | 4 | 0.110 |
Why?
| | Mastoid | 1 | 2015 | 12 | 0.110 |
Why?
| | Patient-Specific Modeling | 1 | 2015 | 45 | 0.110 |
Why?
| | Dissection | 1 | 2015 | 56 | 0.110 |
Why?
| | Intraoperative Care | 1 | 2015 | 62 | 0.110 |
Why?
| | Purpura | 1 | 2014 | 18 | 0.110 |
Why?
| | Models, Anatomic | 1 | 2015 | 84 | 0.110 |
Why?
| | Ear Auricle | 1 | 2014 | 14 | 0.110 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2014 | 32 | 0.110 |
Why?
| | Ligation | 1 | 2014 | 92 | 0.100 |
Why?
| | Incidence | 1 | 2021 | 2883 | 0.100 |
Why?
| | Salivary Glands | 1 | 2014 | 36 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2019 | 642 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 710 | 0.100 |
Why?
| | Vasculitis | 1 | 2014 | 69 | 0.100 |
Why?
| | United States | 3 | 2021 | 15988 | 0.100 |
Why?
| | Injections | 1 | 2014 | 197 | 0.100 |
Why?
| | Anxiety | 1 | 2021 | 1110 | 0.100 |
Why?
| | Neuromuscular Agents | 1 | 2014 | 45 | 0.100 |
Why?
| | Necrosis | 1 | 2014 | 244 | 0.100 |
Why?
| | Botulinum Toxins, Type A | 1 | 2014 | 58 | 0.100 |
Why?
| | Upper Extremity | 1 | 2014 | 112 | 0.100 |
Why?
| | Self Report | 1 | 2017 | 873 | 0.090 |
Why?
| | Linear Models | 1 | 2015 | 854 | 0.090 |
Why?
| | Sex Factors | 1 | 2018 | 2114 | 0.090 |
Why?
| | Adolescent | 4 | 2015 | 22453 | 0.090 |
Why?
| | Cerebral Palsy | 1 | 2014 | 132 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2018 | 11695 | 0.090 |
Why?
| | Depression | 1 | 2021 | 1559 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1540 | 0.080 |
Why?
| | Risk Factors | 2 | 2025 | 10792 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 583 | 0.080 |
Why?
| | Quality of Life | 2 | 2020 | 3192 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2020 | 8279 | 0.080 |
Why?
| | Computer Simulation | 1 | 2015 | 1026 | 0.080 |
Why?
| | Infant | 2 | 2015 | 10039 | 0.080 |
Why?
| | Endoscopy | 2 | 2023 | 316 | 0.070 |
Why?
| | Prospective Studies | 3 | 2020 | 7997 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1141 | 0.070 |
Why?
| | Cell Shape | 1 | 2009 | 57 | 0.070 |
Why?
| | Substance P | 1 | 2009 | 39 | 0.070 |
Why?
| | Paneth Cells | 1 | 2009 | 20 | 0.070 |
Why?
| | Chromogranin A | 1 | 2009 | 43 | 0.070 |
Why?
| | Transduction, Genetic | 1 | 2009 | 133 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 3082 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 276 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2015 | 2947 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2009 | 233 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1490 | 0.060 |
Why?
| | Syndrome | 1 | 2025 | 380 | 0.050 |
Why?
| | Genotype | 1 | 2009 | 1835 | 0.050 |
Why?
| | Pitch Perception | 1 | 2023 | 14 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2185 | 0.050 |
Why?
| | Cell Line | 1 | 2009 | 2882 | 0.050 |
Why?
| | Auditory Perception | 1 | 2023 | 114 | 0.050 |
Why?
| | Cranial Fossa, Middle | 1 | 2022 | 19 | 0.050 |
Why?
| | Craniotomy | 1 | 2022 | 82 | 0.040 |
Why?
| | Hearing | 1 | 2023 | 132 | 0.040 |
Why?
| | Liver | 1 | 2010 | 1888 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2025 | 354 | 0.040 |
Why?
| | Phenotype | 1 | 2009 | 3164 | 0.040 |
Why?
| | Rats | 1 | 2009 | 5614 | 0.040 |
Why?
| | Surgical Flaps | 1 | 2021 | 142 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2609 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2020 | 3415 | 0.040 |
Why?
| | Tongue Neoplasms | 1 | 2019 | 25 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 509 | 0.030 |
Why?
| | Auditory Threshold | 1 | 2015 | 51 | 0.030 |
Why?
| | Tympanic Membrane | 1 | 2015 | 21 | 0.030 |
Why?
| | Electrophysiology | 1 | 2014 | 218 | 0.030 |
Why?
| | Cadaver | 1 | 2015 | 304 | 0.030 |
Why?
| | Postoperative Period | 1 | 2014 | 354 | 0.020 |
Why?
| | Deafness | 1 | 2014 | 78 | 0.020 |
Why?
| | Education, Medical | 1 | 2015 | 276 | 0.020 |
Why?
| | Mice | 1 | 2009 | 18365 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 14126 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5417 | 0.020 |
Why?
| | Animals | 1 | 2009 | 38109 | 0.020 |
Why?
|
|
Formeister's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|